MannKind

2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
M&A
Pfizer
Merck
Genzyme
Sanofi
JNJ
Crucell
ONYX Pharmaceuticals
Bayer
Momenta
Novartis
GSK
Human Genome Sciences
Vertex Pharmaceuticals
MannKind
Vivus
Savient
FDA Delay of MannKind's Inhaled Insulin Is Mostly Positive News
Seeking Alpha
Thu, 12/30/10 - 11:12 am
MannKind
FDA
Afrezza
inhaled insulin
FDA Delay Could Be Very Bad Omen For MannKind
Forbes
Tue, 12/28/10 - 03:59 pm
FDA
MannKind
inhaled insulin
Afrezza
MannKind Says FDA Will Take Another Four Weeks on Insulin Decision
WSJ Online
Tue, 12/28/10 - 01:08 pm
FDA
inhaled insulin
MannKind
Afrezza
Will the FDA Be Kind to MannKind?
Motley Fool
Wed, 12/22/10 - 04:36 pm
FDA
MannKind
inhaled insulin
Afrezza
Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Vertex Pharmaceuticals
Telaprevir
Merck
hepatitis C
cystic fibrosis
Human Genome Sciences
Benlysta
lupus
MannKind
Afrezza
inhaled insulin
MannKind Shares Plunged: What You Need to Know
Motley Fool
Thu, 12/16/10 - 12:48 pm
MannKind
Afrezza
insulin
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Neutral on MannKind
Yahoo/Zacks
Sat, 12/11/10 - 11:39 am
MannKind
Afrezza
inhaled insulin
diabetes
Clearing Up the Uncertainty Around MannKind’s Afrezza
Seeking Alpha
Wed, 12/8/10 - 10:01 am
MannKind
inhaled insulin
Afrezza
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
A Small Step Back for MannKind?
Seeking Alpha
Sun, 11/7/10 - 11:29 am
MannKind
inhaled insulin
Is MannKind a Bad News Buy?
Motley Fool
Sat, 11/6/10 - 12:59 pm
MannKind
inhaled insulin
Afrezza
diabetes
MannKind Falls After Lawsuit Alleges Unlawful Clinical Trial Conduct
Bloomberg
Thu, 11/4/10 - 10:00 pm
MannKind
lawsuits
diabetes
fraud
Afrezza
MannKind Accused of Data Fraud Coverup
TheStreet.com
Thu, 11/4/10 - 11:33 am
MannKind
fraud
Afrezza
inhaled insulin
diabetes
Loss at MNKD Wider than Expected
Yahoo/Zacks.com
Mon, 11/1/10 - 11:25 am
MannKind
earnings
Pfizer
[video] For All MannKind?
CNBC
Fri, 10/15/10 - 10:38 am
inhaled insulin
MannKind
Afrezza
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Biodel's Linjeta Should Overcome the Usual FDA Approval Hurdles
Seeking Alpha
Wed, 09/15/10 - 10:46 am
FDA
Biodel
Linjeta
diabetes
MannKind
inhaled insulin
Afrezza
insulin injectables

Pages